Industry News
Genetic Technologies reports $3.3m 1H loss
Genetic Technologies (ASX:GTG) has reported a $3.3m loss for 1H12, as a result of declining diagnostics and patent licensing revenue. [ + ]
Coridon developing next-gen HPV vaccine
Ian Frazer and the team at Coridon is working on a new vaccine that will also provide treatment for human papillomavirus (HPV) in infected women. [ + ]
Allied announces Coridon to develop HPV therapeutic vaccine
The board of Allied Healthcare Group has announced that its investment company Coridon has embarked on the development of a next-generation therapeutic Human Papillomavirus (HPV) vaccine. The program will be based on preliminary work by Coridon founder Professor Ian Frazer’s team and follows on from Professor Frazer’s work that resulted in two successful cervical cancer preventative vaccines - Gardasil and Cervarix. [ + ]
DuPont and the Australian Centre for Plant Functional Genomics collaborate on wheat production
DuPont and the Australian Centre for Plant Functional Genomics (ACPFG) have expanded their long-standing research collaboration to increase research scale on improving the overall productivity of wheat, as well as other crops. [ + ]
Patent reform bill passes Senate
The Raising the Bar bill, which tightens Australian patent laws, including adding an exemption for researchers, has cleared the Senate and will move to the House of Representatives. [ + ]
Partner & exhibitor packages now open for AusBiotech 2012
Partnership and exhibition packages are now available for the AusBiotech 2012 national conference to be held in Melbourne, Victoria from 30 October to 2 November 2012. [ + ]
Phylogica wins US peptide patent
Perth-based Phylogica (ASX:PYC) has received a US patent for one of its Phylomer library of peptides with potential drug development leads. [ + ]
Ancient penguin DNA is key to conservation
Conservation of the King Penguin is proving successful following research showing that the species has recovered past genetic diversity in just 80 years, despite a prior threat of extinction. [ + ]
Working group on promotion of therapeutic products
Key industry stakeholders have been debating whether or not companies should prescribe to a harmonised code of conduct to achieve TGA registration. [ + ]
NSW Scientist of the Year makes breakthrough in race to develop quantum computer
A team of world-leading Sydney scientists has made a major breakthrough in the race to develop the first quantum computer that will perform tasks a billion times faster than computers today. The team, led by 2011 NSW Scientist of the Year Professor Michelle Simmons, has built the world’s smallest transistor by precisely positioning a single phosphorus atom in a silicon crystal. [ + ]
UWA launches powerful DNA sequencer
Researchers at the University of Western Australia (UWA) have launched the Hi-Seq Illumina Deep Sequencer, the most powerful platform worldwide for next-generation sequencing. In a single day of use, at the cost of a few thousand dollars, this technology will allow researchers to obtain the sequence equivalent of the entire human genome project. [ + ]
Start-up Vitality signs APAC distribution deals
Vitality Devices, a new Australian company founded to commercialise medical devices in Asia-Pacific, has signed its first two distribution deals. [ + ]
Gene patents challenged in court
In the middle of the patent fight over the BRCA1 gene mutation, Genetic Technologies (ASX:GTG) announced a new settlement in the rash of infringement suits covering its non-coding DNA patent. [ + ]
Vitamin C may enhance radiation therapy for aggressive brain tumours
Recent research by the University of Otago, Wellington, has shown that giving brain cancer cells high dose vitamin C makes them much more susceptible to radiation therapy. [ + ]
AusBiotech international investment showcase events in Hong Kong and New York
AusBiotech is calling for expressions of interest to participate in two international showcase events in Hong Kong and New York. [ + ]